HB 3307 allocates $5 million from Oklahoma's General Revenue Fund to establish a revolving fund specifically for veterans' traumatic brain injury (TBI) treatment and recovery services. The funding supports the Oklahoma Department of Veterans Affairs in providing TBI care to eligible veterans, directly benefiting veterans with TBI injuries who access state veterans' services. The bill becomes effective July 1, 2026, and declares an emergency to allow immediate implementation upon approval. This is a funding measure with no new policy requirements, solely providing financial resources for existing TBI treatment programs.
SB 1427 requires all Oklahoma children to be screened for type 1 diabetes during routine checkups at ages 5 and 12 by their primary care providers, using accepted medical practices. The bill mandates that these screenings be reimbursed through Oklahoma's Medicaid program (pending federal approval) and directs the State Department of Health to seek additional funding to support the screenings. The Oklahoma Health Care Authority Board and State Commissioner of Health must create implementing rules for reimbursement and screening protocols. This law applies to all children in Oklahoma and takes effect November 1, 2026.
SB 1844, the "Hope for Oklahoma Patients Act," allows eligible Oklahoma patients with life-threatening or severely debilitating conditions to access genetically tailored investigational treatments (like personalized gene therapies or vaccines) when all FDA-approved options have been exhausted. It defines "eligible patients" as those meeting strict medical criteria, including physician attestation and written consent, and requires treatments to be based on the patient’s unique genetic profile. The bill makes participation voluntary for healthcare facilities and manufacturers (who may choose not to provide treatments), requires patients to cover manufacturing costs, and clarifies that insurers and government entities are not obligated to cover these treatments. It explicitly excludes treatments derived from embryonic stem cells or abortion-related materials and prohibits state entities from interfering with provider discretion.
HB 3013 requires all final harvest and production batch samples of medical marijuana to be tested for certain pesticides. The bill establishes a new license category for medical marijuana testing laboratories and mandates that Oklahoma’s Medical Marijuana Authority develop specific testing protocols, including pesticide residue standards. It prohibits owners of medical marijuana businesses (dispensaries, growers, or processors) from owning testing labs and requires labs to operate independently to ensure unbiased results. This law applies directly to medical marijuana businesses, testing facilities, and the Oklahoma Medical Marijuana Authority, requiring them to comply with new pesticide testing requirements starting in 2024.
HB 4261 updates Oklahoma's rules for distributing opioid settlement funds to local governments. It defines "approved purposes" for grant spending - including treatment access, prevention programs, naloxone distribution, and recovery services - and prohibits using funds for non-approved activities. The bill clarifies the Oklahoma Opioid Abatement Board's role in awarding grants, requiring grantees to submit documentation, and establishes procedures for contract appeals. It directly affects political subdivisions (counties, cities) receiving opioid abatement grants funded by settlements like the Purdue agreement. The changes aim to streamline grant administration while ensuring funds address the opioid crisis per state law.
HB 4279 creates a special revolving fund called the "Oklahoma Department of Veterans Affairs Revolving Nonappropriated Veteran Care Enterprise Fund" to support care at state veterans' homes in Ardmore, Claremore, Clinton, Lawton/Ft. Sill, Norman, Sulphur, and Sallisaw. The fund is financed by patient fees, gifts, donations, and other non-federal revenue (excluding state/federal grants), and can cover care costs, facility maintenance, staff salaries, and medical improvements for veterans. It requires the Department to maintain separate accounting, submit quarterly financial reports to the Governor and legislature, and comply with federal audit standards. The bill exempts the fund from standard state treasury procedures but does not change existing funding sources like state appropriations.
HB 3807 prohibits Oklahoma insurers from refusing coverage or charging higher rates to widowed individuals based on their marital status reflecting the death of a spouse. The bill directly affects widowed residents purchasing insurance policies in Oklahoma by requiring insurers to treat them the same as married individuals for rate and coverage purposes. Key provisions ban insurers from denying coverage or charging different premiums solely due to widowhood, ensuring equal treatment regardless of marital status after a spouse's death. The law takes effect November 1, 2026, and applies to all insurance policies covered under Oklahoma Statutes Title 36. This is a direct policy change preventing discrimination against widowed people in insurance markets.
HB 4293, the "Veterans Mental Health Innovation Act," allows Oklahoma universities and affiliated research facilities to conduct clinical trials using ibogaine - a substance derived from the Tabernanthe iboga plant - to treat specific medical conditions. It authorizes research for conditions like PTSD, treatment-resistant depression, opioid use disorder, and chronic pain, requiring registration with state health and agriculture agencies and annual reporting. Researchers and qualifying patients participating in approved trials receive legal immunity from penalties for ibogaine use, possession, or distribution under strict compliance with the bill’s requirements. The law explicitly states it does not decriminalize ibogaine for general use, focusing solely on regulated research. All activities must follow detailed study protocols and submit final reports to state legislative leaders.
HB 4412 creates a permanent revolving fund in Oklahoma's State Treasury called the "ADvantage Waiver Home and Community-based Services for Seniors Revolving Fund." This fund, managed by the Oklahoma Health Care Authority, will provide home and community-based care services to seniors who would otherwise require nursing facility placement but choose to remain in home or community settings instead. The fund will be financed using state and federal funds, donations, grants, and other designated contributions, with no annual budget restrictions. It becomes effective July 1, 2026, to support seniors seeking alternatives to nursing home care.
HB 3286 requires all health insurance plans in Oklahoma to cover pregnancy, postpartum, and newborn care services - including support from perinatal doulas, nurse-midwives, and lactation consultants - without cost-sharing like deductibles or copays. It mandates coverage for breast pumps, supplies, feeding aids, and home visits for postpartum support for at least one year after birth. The bill also exempts breast pumps, supplies, and feeding aids from state sales and use taxes. These provisions apply to both private insurance and Oklahoma’s Medicaid program (SoonerCare), directly affecting pregnant individuals, new parents, and healthcare providers.
